Envestnet Asset Management’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-114,274
| Closed | -$5.04M | – | 4550 |
|
2025
Q1 | $5.04M | Sell |
114,274
-7,489
| -6% | -$330K | ﹤0.01% | 2119 |
|
2024
Q4 | $4.4M | Buy |
121,763
+1,507
| +1% | +$54.4K | ﹤0.01% | 2192 |
|
2024
Q3 | $3.85M | Buy |
120,256
+7,830
| +7% | +$251K | ﹤0.01% | 2267 |
|
2024
Q2 | $4.24M | Buy |
112,426
+40,781
| +57% | +$1.54M | ﹤0.01% | 2136 |
|
2024
Q1 | $3.53M | Buy |
71,645
+5,518
| +8% | +$272K | ﹤0.01% | 2218 |
|
2023
Q4 | $2.41M | Buy |
66,127
+4,780
| +8% | +$174K | ﹤0.01% | 2348 |
|
2023
Q3 | $1.42M | Buy |
61,347
+39,902
| +186% | +$923K | ﹤0.01% | 2563 |
|
2023
Q2 | $562K | Buy |
21,445
+5,431
| +34% | +$142K | ﹤0.01% | 3138 |
|
2023
Q1 | $412K | Buy |
16,014
+4,538
| +40% | +$117K | ﹤0.01% | 3275 |
|
2022
Q4 | $298K | Sell |
11,476
-2,925
| -20% | -$76.1K | ﹤0.01% | 3429 |
|
2022
Q3 | $411K | Buy |
14,401
+558
| +4% | +$15.9K | ﹤0.01% | 3140 |
|
2022
Q2 | $341K | Sell |
13,843
-2,553
| -16% | -$62.9K | ﹤0.01% | 3287 |
|
2022
Q1 | $925K | Buy |
16,396
+5,763
| +54% | +$325K | ﹤0.01% | 2727 |
|
2021
Q4 | $659K | Buy |
10,633
+2,705
| +34% | +$168K | ﹤0.01% | 2900 |
|
2021
Q3 | $503K | Buy |
+7,928
| New | +$503K | ﹤0.01% | 2961 |
|